HORIZON-EIC-2023-ACCELERATORCHALLENGES-01
EIC Accelerator Challenge: Novel biomarker-based assays to guide personalised cancer treatment
Plain-language summary
EIC Accelerator Challenge for novel biomarker assays to personalize cancer treatment.
This call seeks innovative biomarker-based assays to guide personalized cancer therapies. It supports projects aiming to improve cancer treatment precision. Multiple submission cut-offs allow repeated applications.
Likely relevant for
- biomedical startups
- cancer diagnostics developers
- personalized medicine innovators
- biotechnology SMEs
Project signals
development of novel biomarker assaysprojects targeting cancer treatment personalizationinnovation in diagnostic tools
What it funds
- Development and validation of novel biomarker-based assays for cancer treatment guidance
- Innovative diagnostic tools to enable personalized oncology therapies
Expected outcomes
- Improved precision in cancer treatment selection
- Validated assays ready for clinical or commercial use
- Advancement in personalized medicine approaches
Who can apply / participate
- SMEs
- startups
- small mid-caps
- Typically single applicants or small consortia allowed under EIC Accelerator
- Applicants from EU Member States and associated countries
- Must meet EIC Accelerator eligibility criteria
- Focus on innovation with market potential
- Exact consortium size limits
- Specific country eligibility details
Must check before shortlisting
- specific eligibility criteria for EIC Accelerator
- funding rates and budget limits
- consortium requirements if any
Money
Budget details and funding rates are not clearly stated and must be checked in official documents.
Application notes
- Multiple cut-off dates allow applicants to submit proposals repeatedly until the deadline.
- Standard EIC Accelerator application documents required
- Compliance with Horizon Europe rules
- Prepare proposal aligned with biomarker assay innovation
- Submit via the EU Funding & Tenders Portal
- Follow multiple cut-off submission schedule
- Check detailed eligibility and evaluation criteria
- Ensure readiness for blended finance model
Derived from official EU Funding portal source · updated 2 Jul 2026, 10:21 UTC. Use this as a shortlisting aid; the official call text remains authoritative.
Official source text
Fine print from the EU source record. Expand when you need the original wording.